Role of Tissue-Derived Plasminogen Activator (t-PA) in an Excitotoxic Mouse Model of Neonatal White Matter Lesions

Abstract

White matter (WM) lesions in preterm newborns may lead to cerebral palsy. To study WM lesions in a mouse model, we used intrapallial stereotactic injections of ibotenic acid, an N-methyl-D-aspartate receptor agonist. Previous studies support a contribution of tissue-type plasminogen activator (t-PA) to the brain lesions seen in various adult excitotoxic models. Therefore, we studied both 5-day-old (P5) wild-type mice and t-PA knock-out (t-PA^−/−) mice. The ibotenic acid doses required to induce WM cysts were lower in the wild-type mice (EC₅₀ < 0.01 μg/animal) than in the t-PA^−/− mice (EC₅₀ = 2.5 μg/animal) (p < 0.01), indicating the existence of t-PA–dependent and t-PA–independent mechanisms. Dose-dependent prolonged cyst growth occurred in the wild-type mice only. Early microglial activation and astrogliosis were similar in the wild-type and t-PA^−/− mice. In adult mice (P45), demyelination occurred at the injection site in both groups but the astroglial scar was denser in the wild-type than in the t-PA^−/− mice. These data support involvement of t-PA at several stages of WM lesion formation. Inactivation of t-PA might confer protection by prolonged hemostasis. The role of t-PA in cyst expansion suggests a new approach to the development of neuroprotective strategies in infants with developing WM lesions.

Astrocytes, Glial fibrillary acidic protein, Hemosiderin, Ibotenic acid, Microglia, Myelin basic protein, Neurofilament